Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare conventional treatment of congestive heart failure (CHF) with two experimental interventions: amiodarone and an implantable cardioverter-defibrillator (ICD).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Amiodarone

Criteria

Patients with New York Heart Association class II or class III heart failure and ejection fraction less than or equal to 35%.